| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e29526f284c0155fd79806c9dd5a1c7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2016-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cf3fe94cc4ced23d2ad3c4ee0d16d0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e42d54487540213ae0bc5aed3a87e49b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_613597b51a292687f7313a120b716abf |
| publicationDate |
2017-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017022280-A1 |
| titleOfInvention |
Method for treating antibody-mediated rejection post-transplantation |
| abstract |
Described herein are methods for treating antibody mediated rejection of transplanted organs using inhibitors of IL-6. In one embodiment, the IL-6 inhibitor is Tocilizumab and is administered simultaneously or sequentially with intravenous immunoglobulin (IVIG). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108452328-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113194996-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020132600-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3737414-A4 |
| priorityDate |
2015-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |